374 results on '"Lam, John S."'
Search Results
2. Staging of Renal Cell Carcinoma
3. Ureteral Stents
4. Surveillance for renal cell carcinoma: Why and how? When and how often?
5. In Vivo Efficacy of Laparoscopic Assisted Percutaneous Renal Cryotherapy: Evidence Based Guidelines for the Practicing Urologist
6. EDITORIAL COMMENT
7. EDITORIAL COMMENT
8. Platelet Count and Preoperative Haemoglobin Do Not Significantly Increase the Performance of Established Predictors of Renal Cell Carcinoma-Specific Mortality
9. Use of Haemostatic Agents and Glues during Laparoscopic Partial Nephrectomy: A Multi-Institutional Survey from the United States and Europe of 1347 Cases
10. Long-term outcomes of the surgical management of renal cell carcinoma
11. Prognostic Relevance of Tumour Size in T3a Renal Cell Carcinoma: A Multicentre Experience
12. Morbidity and Clinical Outcome of Nephron-Sparing Surgery in Relation to Tumour Size and Indication
13. Open partial nephrectomy for the treatment of renal cell carcinoma
14. Prognostic Impact of Tumor Size on pT2 Renal Cell Carcinoma: An International Multicenter Experience
15. Metachronous Bilateral Renal Cell Carcinoma: Risk Assessment, Prognosis and Relevance of the Primary-Free Interval
16. Ureteropelvic Junction Obstruction
17. Novel approaches in the therapy of metastatic renal cell carcinoma
18. G250: A carbonic anhydrase IX monoclonal antibody
19. Surveillance following radical or partial nephrectomy for renal cell carcinoma
20. The role of lymphadenectomy in renal cell carcinoma
21. Use of prostatic stents for the treatment of benign prostatic hyperplasia in high-risk patients
22. RENCA/carbonic anhydrase-IX: A murine model of a carbonic anhydrase-IX-expressing renal cell carcinoma
23. Editorial Comment
24. Role of molecular markers in the diagnosis and therapy of renal cell carcinoma
25. POSTOPERATIVE SURVEILLANCE PROTOCOL FOR PATIENTS WITH LOCALIZED AND LOCALLY ADVANCED RENAL CELL CARCINOMA BASED ON A VALIDATED PROGNOSTIC NOMOGRAM AND RISK GROUP STRATIFICATION SYSTEM
26. Importance of surgical margins in the management of renal cell carcinoma
27. NEPHRON-SPARING SURGERY VS. RADICAL NEPHRECTOMY IN PATIENTS WITH RENAL CELL CARCINOMA >7 CM. WITH NO EVIDENCE OF NODAL OR DISTANT METASTATSIS: 1216
28. PREDICTIVE FACTORS FOR LOCAL RECURRENCE AFTER NEPHRON SPARING SURGERY IN RENAL CELL CARCINOMA: 1094
29. PARTIAL NEPHRECTOMY FOR RENAL MASSES: CAN WE APPLY THE QUALITY OF CARE CONCERN ADDRESSED BY THE UROLOGICAL COMMUNITY, TO THE EUROPEAN POPULATION?: 610
30. Flexible Ureteroscopy and Laser Lithotripsy for Single Intrarenal Stones 2 cm or Greater—Is This the New Frontier?
31. Unclassified renal cell carcinoma: an analysis of 85 cases
32. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience
33. Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection
34. Is laparoscopic donor nephrectomy the new standard?
35. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma
36. Kidney cancer management in 2004: An update for the practicing general urologist
37. Evolving Principles of Surgical Management and Prognostic Factors for Outcome in Renal Cell Carcinoma
38. Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score
39. Secondary Hormonal Therapy for Advanced Prostate Cancer
40. Open surgical management of renal cell carcinoma in the era of minimally invasive kidney surgery
41. Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options
42. Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma
43. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma
44. Staging of renal cell carcinoma: current concepts
45. Changing Concepts in the Surgical Management of Renal Cell Carcinoma
46. Update on ureteral stents
47. Changing aspects in the evaluation and treatment of patients with benign prostatic hyperplasia
48. SAFETY AND EFFICACY OF PARTIAL NEPHRECTOMY FOR ALL T1 TUMORS BASED ON AN INTERNATIONAL MULTICENTER EXPERIENCE
49. EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS PREDICTS BONE METASTASIS IN PATIENTS PRESENTING WITH RENAL CELL CARCINOMA: IMPLICATION FOR PREOPERATIVE BONE SCANS
50. Advances in immune-based therapies of renal cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.